대한골관절종양학회지 (The Journal of the Korean bone and joint tumor society)

  • 제17권2호
  • /
  • Pages.79-86
  • /
  • 2011
  • /
  • 1226-4962(pISSN)
  • /
  • 2233-9841(eISSN)
대한근골격종양학회 (The Korean Musculoskeletal Tumor Society)
권호 표지
DOI QR코드

DOI QR Code

골육종 환자에서 종양 대치물을 이용한 재건술의 치료결과

Outcome of Tumor Prosthetic Reconstruction in Osteosarcoma Patient

  • 김재도 (고신대학교 복음병원 정형외과) ;
  • 김충규 (고신대학교 복음병원 정형외과) ;
  • 정소학 (고신대학교 복음병원 정형외과)
  • Kim, Jae-Do (Department of Orthopedic Surgery, Kosin University Gospel Hospital) ;
  • Kim, Cheung-Kue (Department of Orthopedic Surgery, Kosin University Gospel Hospital) ;
  • Chung, So-Hak (Department of Orthopedic Surgery, Kosin University Gospel Hospital)
  • 투고 : 2011.05.21
  • 심사 : 2011.11.30
  • 발행 : 2011.12.30
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

목적: 골육종 치료에 있어서 사지 구제술이 보편화되었다. 이 중 수술 수기가 간편하고, 기능적인 회복이 빠른 종양 대치물을 재건 방법으로 사용하고 있을 뿐만 아니라, 다른 생물학적 구제술이나 관절 고정술 등의 합병증으로 인하여 이차적으로 종양 대치술을 사용되고 있다. 본 연구는 광범위 절제술 이후, 일차적으로 종양 대치술을 시행하는 방법의 장기 추시상 결과를 환자 및 종양 대치물의 생존, 기능적 결과, 합병증 측면에서 보고하고자 한다. 대상 및 방법: 1989년 2월부터 2006년 12월까지 본원에서 골육종으로 진단받은 158예 중, 5년 이상 추시관찰이 가능하고 일차적으로 종양 대치물을 이용한 재건술을 시행하였던 48예를 대상으로 하였다. 추시 기간은 최소 60개월에서 최대 179개월이었다. 남자 28예, 여자 20예 였으며, 평균 나이는 22.4 (11-71세)였다. 병리학적 분류상 전형적인 중심성 골육종 46예, 골막성 2예이었다. 골육종 부위는 근위 경골 26예, 원위 대퇴골 20예, 대퇴골 간부, 경골 간부 각 1예이었다. 종양 대치물의 종류는 41예에서 조립형 종양 대치물을, 7예에서는 확장형 종양 대치물을 이용하여 재건술을 시행하였다. 술 후 기능적 평가를 위해 Musculoskeletal Tumor Society (MSTS) Grading System을 이용하였으며, 환자 및 종양 대치물의 생존율, 합병증에 대해 분석하였다. 결과: 환자의 5년 전체 생존율은 77.7%이었고, 5년 무병 생존율은 68.9%이었다. 종양 대치물의 생존율은 68%이었다. 일차적 치환술을 시행한 48예 중 총 20예에서 합병증이 발생하였으며, 감염이 10예로 가장 많았다. 수술적 치료 술 후 MSTS 기능적 평가는 74.1%이었다. 결론: 일차적 종양 대치술의 장기 추시 결과상 골종양 절제 후 재건 방법으로 생존율, 기능적 평가 및 합병증 측면에서 효과적인 방법이라고 사료된다.

Purpose: Modular tumor prosthesis is the most popular recontructive modality after resection of malignat tumor in extremity. Complications and survival of tumor prosthesis reconstruction are well-known. however, reports on the long-term outcome of tumor prosthesis in osteosarcoma patientss are scarece. Materials and Methods: In 158 cases as diagnosed as osteosarcoma from feburary 1989 to December 2006 in a single cancer center. We retrospectively reviewd 48 osteosarcoma patients who under went tumor prosthetic reconstruction. Mean follow up preiod was 75.6 months (range; 60 to 179 months). There were 28 males, 20 females and mean age was 22.4 years (range; 11-71). Pathologic subtypes were conventional central osteosarcoma in 46 cases and periosteal in 2 cases. The location of the tumor was proximal tibia (26 cases), distal femor (20 cases), femor diaphysis (1 case), and tibia diaphysis (1 case). In 41 cases built-up-type tumor prosthesis have been used and 7 cases expansion-type tumor prosthesis have been used. We used Musculoskeletal tumor society (MSTS) grading system to asses post operation function, and we analyzed survival rate of patient and tumor prosthesis and complication. Results: The overall survival rate was 77.7% and disease free survival rate was 68.9%. The survival rate of tumor prosthesis was 73%, in last follow up tumor prosthesis has been removed in 12 cases. All of them, 17 complications occurred, which included infection in 16 cases, Periprosthetic Fracture and Loosening of tumor prosthesis in 4 cases, articular instability in 4 cases. MSTS functional score was 74.1% in post operation. Conclusion: In long term follow up result, Primary tumor prosthesis -a reconstruction method after a wide extensional resecion of a bone tumor- can be a effective treatment method in asepect of survival rate, functional assesment and complication.

키워드

참고문헌

  1. Abudu A, Carter SR, Grimer RJ. The outcome and functional results of diaphyseal endoprosheses after tumor excision. J Bone and Joint Surg. 1996;78B:652-7.
  2. Rougraff BT, Simmon MA, Kneisl JS, Greenberg DB, Mankin HJ. Limb salvge compaired with amputation for osteosarcoma of the distal end of the femur: a long-term oncological, functional, and quality of life study. J Bone and Joint Surg. 1994;76:649. https://doi.org/10.2106/00004623-199405000-00004
  3. Grimmer RJ, Carter SR, Tillman RM, et al. Endoprosthetic replacement of the proximal tibia. J Bone Joint Surg. 1999;81B:488-94.
  4. Kabukcuoglu Y, Grimmer RJ, Tillmann RM, Carter SR. Endoprosthetic replacement for primary maligant tumors of the proximal femur. Clin Orthop. 1999;358:8-14.
  5. Kawai A, Muschler GF, Lane JM, Otis JC, Healey JH. Prosthetic knee replacement after resection of maligant tumor of the distal part of the femur. J Bone Joint Surg Am. 1998;80:636-47. https://doi.org/10.1302/0301-620X.80B4.8216
  6. Lee SH, Oh JH, Yoo KH, et al. Evaluation of Prosthetic Reconstruction in Lower Extremity. J Korean Bone Joint Tumor Soc. 2002;8:46-9.
  7. Chung SH, Cho Y, Kim JD. Recycling total joint autotransplantation in osteosarcoma around knee joint. J Korean Bone Joint Tumor Soc. 2007;13:31-6.
  8. Dick HM, Malinin TI, Mnaymn WA. Massive allograft implantations following radical resection of high-grade tumors requiring adjuvant chemotherapy treatment. Clin Orthop Relat Res. 1985;197:88-95.
  9. Gosheger G, Gebert C, Ahrens H, Streitbuerger A, Winkelmann W, Hardes J. Endoprosthetic reconstruction in 250 patients with osteosarcoma. Clin Orthop Relat Res. 2006;450:164-71. https://doi.org/10.1097/01.blo.0000223978.36831.39
  10. Hardes J, Gebert C, Schwappach A, et al. Characteristic and outcome of infections associated with tumor endoprostheses. Arch Orthop Trauma Surg. 2006;126:289-96. https://doi.org/10.1007/s00402-005-0009-1
  11. Hillmann A, Hoffmann C, Gosheger G, Krakau H, Winkelmann W. Malignant tumor of the distal part of the femur or the proximal part of the tibia: endoprosthetic replacement or rotationplasty. Functional outcome and quality-of life measurements. J Bone Joint Surg Am. 1999;81:462-8. https://doi.org/10.1302/0301-620X.81B3.9134
  12. Lindner NJ, RAMM O, Hillmann A, et al. Limb salvage and outcome of osteosarcoma. The University of Muenster experience. Clin Orthop. 1999;358:83-9. https://doi.org/10.1097/00003086-199901000-00011
  13. Quill G, Gitelis S, Morton T, Piasecki P. Complications associated with limb salvage for extremity sarcomas and their management. Clin Orthop. 1990;260:242-50.
  14. Sanjayy BK, Moreau PG. Limb salvage surgery in bone tumor with modular endoprosthesis. Int Orthop. 1999;23:41-6. https://doi.org/10.1007/s002640050301
  15. Eckardt JJ, Kabo MK, Kelly CM, et al. Expandible endoprosthesis reconstruction in skeletally immature patients with tumors. Clin Orthop. 2000;373:51-61. https://doi.org/10.1097/00003086-200004000-00008
  16. Hornicek FJ, Gebhardt MC, Sorger JI, Mankin HJ. Tumor reconstruction. Orthop Clin N AM. 1999;30:673-84. https://doi.org/10.1016/S0030-5898(05)70119-X
  17. Kneisl JS, Finn HA, Simon MA. Mobile knee reconstruction after resection of malignant tumors of the distal femur. Orthop Clin N Am. 1991;22:105-19.
  18. Enneking WF, Mindell ER. Observations on massive retrieved human allografts. J Bone Joint Surg. 1991;73:1123-42. https://doi.org/10.2106/00004623-199173080-00002
  19. Jensen KL, Johnston JO. Proximal humeral reconstruction after excision of a primary sarcoma. Clin Orthop Relat Res. 1995;(311):164-75.
  20. Kohler P, Kreicberg A. Chondrosarcoma treated by reimplantation of resected bone aft er autoclaving and supplement with allogenic bone matrix. Clin Orthop Relat Res. 1993;(294):281-4.
  21. Unwin PS, Cobb JP, Walker PS. Distal femoral arthroplsty using custom-made prostheses. The first 218 cases. J Arthroplasty. 1993;8:259-68. https://doi.org/10.1016/S0883-5403(06)80087-2
  22. Eckardt JJ, Paebody TD. Complications of Prostehtic Reconstructions. Surgery for Bone and Soft tissue Tumors. 1998;467-79.
  23. Tsuchiya H, Tomita K. Prognosis of osteosarcoma treated by limb-salvage surgey: the ten-year intergroup study in Japan Jpn J Clin Oncol. 1992;22:347-53. https://doi.org/10.1093/oxfordjournals.jjco.a039576
  24. Schiller C, Windhager R, Fellinger EJ, Salzer-Kuntschik M, Kalder A, Kotz R. Extendable tumour endoprostheses for the leg in children. J Bone Joint Surg Br. 1995;77:608-14. https://doi.org/10.2106/00004623-199504000-00016
  25. Malawer MM, Chou LB. Prosthetic survival and clinical results with use of large-segment replacements in the treatment of high-grade bone sarcomas. J Bone Joint Surg. 1995;77:1154-65. https://doi.org/10.2106/00004623-199508000-00003
  26. Enneking WF, Dunham W, Gebhardt MC, Malawar M, Pritchard DJ. A system for the functional evaluation of reconstructive procedures after surgical treatment of tumors of the musculoskeletal system. Clin Orthop Relat Res. 1993;(286):241-6.
  27. Robert P, Chan D, Grimmer RJ, Sneath RS, Scales JT. Prosthetic replacement of the distal femur for primary bone tumors. J Bone Joint Surg. 1991;73:762-9.